The Valley Desk

NCT05966493 · Interventional trial

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Overall registry status Recruiting

Phase 2

Conditions Persistent Corneal Epithelial Defect

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov